Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD
Juan F. Burgueño, Adrian Reich, Hajar Hazime, et al.
Inflammatory Bowel Diseases (2020) Vol. 26, Iss. 6, pp. 797-808
Open Access | Times Cited: 163

Showing 1-25 of 163 citing articles:

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection
Aleksandra Synowiec, Artur Szczepański, Emilia Barreto-Durán, et al.
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 2
Open Access | Times Cited: 183
Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions
Bin Wang, Lei Zhang, Yongqiang Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 155
Liposome-mediated detection of SARS-CoV-2 RNA-positive extracellular vesicles in plasma
Bo Ning, Zhen Huang, Brady M. Youngquist, et al.
Nature Nanotechnology (2021) Vol. 16, Iss. 9, pp. 1039-1044
Open Access | Times Cited: 138
Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study
Youn Ho Shin, Jae Il Shin, Sung Yong Moon, et al.
The Lancet Rheumatology (2021) Vol. 3, Iss. 10, pp. e698-e706
Open Access | Times Cited: 116
The Role of Angiotensin Converting Enzyme 2 in Modulating Gut Microbiota, Intestinal Inflammation, and Coronavirus Infection
Josef Penninger, Maria B. Grant, Joseph J.�Y. Sung
Gastroenterology (2020) Vol. 160, Iss. 1, pp. 39-46
Open Access | Times Cited: 128
Immunological co-ordination between gut and lungs in SARS-CoV-2 infection
Shruti Ahlawat, Asha Asha, Krishna Kant Sharma
Virus Research (2020) Vol. 286, pp. 198103-198103
Open Access | Times Cited: 125
COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges
Anup Singh Pathania, Philip Prathipati, Abdul Bakrudeen Ali Ahmed, et al.
Theranostics (2020) Vol. 11, Iss. 2, pp. 731-753
Open Access | Times Cited: 114
Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: A systematic review and meta‐analysis
Anupam Singh, Anuraag Jena, Praveen Kumar, et al.
United European Gastroenterology Journal (2020) Vol. 9, Iss. 2, pp. 159-176
Open Access | Times Cited: 109
Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease
Dana J. Lukin, Anand Kumar, Kaveh Hajifathalian, et al.
Gastroenterology (2020) Vol. 159, Iss. 4, pp. 1541-1544.e2
Open Access | Times Cited: 104
Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation
Elena Campione, Terenzio Cosio, Luigi Rosa, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 4903-4903
Open Access | Times Cited: 103
Covid‐19 and oral diseases: Crosstalk, synergy or association?
Daniela Atili Brandini, Aline Satie Takamiya, Pari Thakkar, et al.
Reviews in Medical Virology (2021) Vol. 31, Iss. 6
Open Access | Times Cited: 95
COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses
Filippo Fagni, David Simón, Koray Taşçılar, et al.
The Lancet Rheumatology (2021) Vol. 3, Iss. 10, pp. e724-e736
Open Access | Times Cited: 94
Neurological consequences of COVID-19: what have we learned and where do we go from here?
Abbas Jarrahi, Meenakshi Ahluwalia, Hesam Khodadadi, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 89
Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19
Jilei Zhang, Shari Garrett, Jun Sun
Genes & Diseases (2020) Vol. 8, Iss. 4, pp. 385-400
Open Access | Times Cited: 87
Microbiome Profiling Using Shotgun Metagenomic Sequencing Identified Unique Microorganisms in COVID-19 Patients With Altered Gut Microbiota
Sijia Li, Siyuan Yang, Yuzheng Zhou, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 65
Oral Pathology in COVID-19 and SARS-CoV-2 Infection—Molecular Aspects
Agnieszka Droździk, Marek Droździk
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1431-1431
Open Access | Times Cited: 48
Chronic inflammation in post-acute sequelae of COVID-19 modulates gut microbiome: a review of literature on COVID-19 sequelae and gut dysbiosis
Najeeha Talat Iqbal, Hana Khan, Aqsa Khalid, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access | Times Cited: 1
Autoimmunity as the comet tail of COVID-19 pandemic
Rossella Talotta, Erle S. Robertson
World Journal of Clinical Cases (2020) Vol. 8, Iss. 17, pp. 3621-3644
Open Access | Times Cited: 64
Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases
Kristin E. Burke, Bharati Kochar, Jessica R. Allegretti, et al.
Inflammatory Bowel Diseases (2020) Vol. 27, Iss. 2, pp. 155-161
Open Access | Times Cited: 62
SARS-CoV-2, More than a Respiratory Virus: Its Potential Role in Neuropathogenesis
Chitra Mohinder Singh Singal, Paritosh Jaiswal, Pankaj Seth
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 13, pp. 1887-1899
Closed Access | Times Cited: 60
Probiotics: A Dietary Factor to Modulate the Gut Microbiome, Host Immune System, and Gut–Brain Interaction
Tetsuji Hori, Kazunori Matsuda, Kenji Oishi
Microorganisms (2020) Vol. 8, Iss. 9, pp. 1401-1401
Open Access | Times Cited: 60
Predicting the response of the dental pulp to SARS-CoV2 infection: a transcriptome-wide effect cross-analysis
Johnah C. Galicia, Pietro Hiram Guzzi, Federico M. Giorgi, et al.
Genes and Immunity (2020) Vol. 21, Iss. 5, pp. 360-363
Open Access | Times Cited: 55
The Incidence and Outcomes of COVID-19 in IBD Patients: A Rapid Review and Meta-analysis
Muhammad Aziz, Rawish Fatima, Hossein Haghbin, et al.
Inflammatory Bowel Diseases (2020) Vol. 26, Iss. 10, pp. e132-e133
Open Access | Times Cited: 54
Temporal Correlation Between Neurological and Gastrointestinal Symptoms of SARS-CoV-2
Mehmet Bostancıklıoğlu
Inflammatory Bowel Diseases (2020) Vol. 26, Iss. 8, pp. e89-e91
Open Access | Times Cited: 51
The gut microbiome as a biomarker of differential susceptibility to SARS-CoV-2
Amar Sarkar, Siobhán Harty, Andrew H. Moeller, et al.
Trends in Molecular Medicine (2021) Vol. 27, Iss. 12, pp. 1115-1134
Open Access | Times Cited: 51
Page 1 - Next Page

Scroll to top